 efficaci antilipopolysaccharid anti-tumor necrosi factor monoclon antibodi neutropen rat model pseudomona sepsi monoclon antibodi mab bacteri lipopolysaccharid lp tumor necrosi factor-alpha tnf partial protect experiment model septic shock addit benefit accru combin anti-tnf anti-lp mab treatment septic shock neutropen rat model activ infect pseudomona anim irrelev mab group anti-tnf mab group mab lp group combin anti-tnf anti-lp mab group none control anim group period neutropenia contrast surviv rate group group group combin monoclon antibodi protect mab serum tnf level infect group mean SE group result combin monoclon antibodi lp tnf addit benefit experiment pseudomona aeruginosa sepsi immunotherapeut approach potenti util manag seriou gram-neg bacteri infect neutropen patient